Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma

BACKGROUND: Post-surgical prognosis is usually poor for combined hepatocellular cholangiocarcinoma (CHCC-CC), a rare primary liver cancer. Although midkine (MK) is a prognostic biomarker for several known cancers, it is not known whether it can be used as such in resectable CHCC-CC. This study exami...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ming-Chun, Chen, Yi-Ju, Chiu, Tai-Jan, Lan, Jui, Liu, Chien-Ting, Chen, Yi-Ching, Tien, Hsin-Ho, Chen, Yen-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830052/
https://www.ncbi.nlm.nih.gov/pubmed/29486735
http://dx.doi.org/10.1186/s12885-018-4146-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830052/
https://www.ncbi.nlm.nih.gov/pubmed/29486735
http://dx.doi.org/10.1186/s12885-018-4146-7

Ejemplares similares